EDGAR Filing Documents for 0001193125-18-050506

Form 424B5 - Prospectus [Rule 424(b)(5)]:

SEC Accession No. 0001193125-18-050506

Filing Date

2018-02-20

Accepted

2018-02-20 17:06:39

Documents

Document Format Files

Seq	Description	Document	Type	Size
1	424B5	d497014d424b5.htm	424B5	434094
2	GRAPHIC	g497014g0220125031998.jpg	GRAPHIC	5949
3	GRAPHIC	g497014g0220125032388.jpg	GRAPHIC	16235
4	GRAPHIC	g497014g0220125032718.jpg	GRAPHIC	14796
5	GRAPHIC	g497014g0220125033118.jpg	GRAPHIC	6255
6	GRAPHIC	g497014g64y61.jpg	GRAPHIC	7304
	Complete submission text file	0001193125-18-050506.txt		505553

Mailing Address 8000 MARINA BOULEVARD SUITE 300 BRISBANE CA 94005-1884

Business Address 8000 MARINA BOULEVARD SUITE 300 BRISBANE CA 94005-1884 (650) 614-5220

Aimmune Therapeutics, Inc. (Filer) CIK: 0001631650 (see all company filings)

IRS No.: 452748244 | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-222333 | Film No.: 18625628
SIC: 2834 Pharmaceutical Preparations